CannaPharmaRX

(OTC) CPMD

Current Price$0.00

Market Cap$1.56M

Since IPO (1999)-100%

5 Year-94%

1 Year-41%

1 Month-8%

CannaPharmaRX Financials at a Glance

Market Cap

$1.56M

Revenue (TTM)

$1.65M

Net Income (TTM)

-$10.82M

EPS (TTM)

-$0.02

P/E Ratio

-0.14

Dividend

$0.00

Beta (Volatility)

-916.05 (Low)

Dividend

$0.00

Beta (Volatility)

-916.05 (Low)

Price

$0.00

Volume

637,932

Open

$0.00

Price

$0.00

Volume

637,932

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Nov 14, 2025

Dividend

$0.00

Beta (Volatility)

-916.05 (Low)

Price

$0.00

Volume

637,932

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Nov 14, 2025

CPMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CannaPharmaRX

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Constantine Nkafu

Website

www.cannapharmarx.com

Headquarters

Calgary, AB T2P 5C5, CA

CPMD Financials

Key Financial Metrics (TTM)

Gross Margin

-120.40%

Operating Margin

-202.65%

Net Income Margin

-654.20%

Return on Equity

41.03%

Return on Capital

N/A

Return on Assets

-164.46%

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.56M

Shares Outstanding

678.50M

Volume

637.93K

Avg. Volume

168.57K

Financials (TTM)

Gross Profit

-$1.99M

Operating Income

-$3.35M

EBITDA

-$9.31M

Operating Cash Flow

-$431.38K

Capital Expenditure

$187.72K

Free Cash Flow

-$436.90K

Cash & ST Invst.

$633.00

Total Debt

$20.97M

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$627.46K

+87.1%

Gross Profit

-$409.45K

+18.6%

Gross Margin

-65.26%

N/A

Market Cap

$1.56M

N/A

Market Cap/Employee

$60.02K

N/A

Employees

N/A

Net Income

-$382.02K

+44.7%

EBITDA

-$682.34K

-1277.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$633.00

-47.6%

Total Debt

$20.97M

+25.1%

Accounts Receivable

$26.01K

-90.9%

Inventory

$902.91K

-5.1%

Long Term Debt

$5.36M

+10.6%

Short Term Debt

$15.61M

+31.0%

Return on Assets

-1.64%

N/A

Return on Invested Capital

13.46%

N/A

Free Cash Flow

-$243.66K

+59.5%

Operating Cash Flow

-$243.66K

+59.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PLSHPanacea Life Sciences Holdings, Inc.

PLSHPanacea Life Sciences Holdings, Inc.$0.07+39.60%

EXMTAnything Technologies Media, Inc.

EXMTAnything Technologies Media, Inc.$0.00+0.00%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00+0.00%

MSTHMystic Holdings, Inc.

MSTHMystic Holdings, Inc.$0.00+0.00%

MJARFMJardin Group, Inc.

MJARFMJardin Group, Inc.$0.00+0.00%

ALIDAllied Corp.

ALIDAllied Corp.$0.00+0.00%

SRUTFSproutly Canada Inc.

SRUTFSproutly Canada Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About CPMD

What is the current price of CannaPharmaRX?

CannaPharmaRX is trading at $0.00 per share.

What is the 52-week range for CannaPharmaRX?

Over the past 52 weeks, CannaPharmaRX has traded between $0.00 and $0.01.

How much debt does CannaPharmaRX have?

As of the most recent reporting period, CannaPharmaRX reported total debt of $20.97M.

How much cash does CannaPharmaRX have on hand?

CannaPharmaRX reported $633.00 in cash and cash equivalents in its most recent financial results.

What is CannaPharmaRX’s dividend yield?

CannaPharmaRX does not currently have a dividend yield.

CannaPharmaRX

CannaPharmaRX Financials at a Glance

CPMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About CannaPharmaRX

CPMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPMD

What is the current price of CannaPharmaRX?

What is the 52-week range for CannaPharmaRX?

How much debt does CannaPharmaRX have?

How much cash does CannaPharmaRX have on hand?

What is CannaPharmaRX’s dividend yield?

Premium Investing Services